{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:32:03Z","timestamp":1784367123116,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T00:00:00Z","timestamp":1414108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1245\/s10434-014-4176-6","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T20:21:28Z","timestamp":1414095688000},"page":"1176-1184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Clinical Features and Outcome of Primary Pancreatic Lymphoma"],"prefix":"10.1245","volume":"22","author":[{"given":"Eran","family":"Sadot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Kinh Gian","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Teruya-Feldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Peter Kingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"DeMatteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,24]]},"reference":[{"issue":"4","key":"4176_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jso.2930050410","volume":"5","author":"SM Baylor","year":"1973","unstructured":"Baylor SM, Berg JW. Cross-classification and survival characteristics of 5,000 cases of cancer of the pancreas. J Surg Oncol. 1973;5(4):335\u2013358.","journal-title":"J Surg Oncol"},{"issue":"1","key":"4176_CR2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","volume":"29","author":"C Freeman","year":"1972","unstructured":"Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29(1):252\u2013260.","journal-title":"Cancer"},{"issue":"5","key":"4176_CR3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00006676-199409000-00019","volume":"9","author":"KE Behrns","year":"1994","unstructured":"Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas. 1994;9(5):662\u2013667.","journal-title":"Pancreas"},{"key":"4176_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/bjs.18004921319","volume":"49","author":"IM Dawson","year":"1961","unstructured":"Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract: report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80\u201389.","journal-title":"Br J Surg"},{"key":"4176_CR5","unstructured":"Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. Available at: http:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/pat-gen\/bb2\/BB2.pdf . Accessed 2 Apr 2014."},{"issue":"Suppl 4","key":"4176_CR6","doi-asserted-by":"crossref","first-page":"iv77","DOI":"10.1093\/annonc\/mdn204","volume":"19","author":"E Zucca","year":"2008","unstructured":"Zucca E. Extranodal lymphoma: a reappraisal. Ann Oncol. 2008;19 Suppl 4:iv77\u201380.","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"4176_CR7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hon.2081","volume":"31","author":"JF Seymour","year":"2013","unstructured":"Seymour JF. X. Extra-nodal lymphoma in rare localisations: bone, breast and testes. Hematol Oncol. 2013;31 Suppl 1:60\u201363.","journal-title":"Hematol Oncol"},{"issue":"1","key":"4176_CR8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2003.11.141","volume":"21","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003;21(1):20\u201327.","journal-title":"J Clin Oncol"},{"issue":"31","key":"4176_CR9","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1200\/JCO.2009.22.5896","volume":"27","author":"JD Gundrum","year":"2009","unstructured":"Gundrum JD, Mathiason MA, Moore DB, Go RS. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol. 2009;27(31):5227\u20135232.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4176_CR10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.mpa.0000227910.63579.15","volume":"33","author":"N Battula","year":"2006","unstructured":"Battula N, Srinivasan P, Prachalias A, Rela M, Heaton N. Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas. 2006;33(2):192\u2013194.","journal-title":"Pancreas"},{"issue":"3","key":"4176_CR11","first-page":"262","volume":"7","author":"MW Saif","year":"2006","unstructured":"Saif MW. Primary pancreatic lymphomas. JOP. 2006;7(3):262\u2013273.","journal-title":"JOP"},{"issue":"1","key":"4176_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000658-198901000-00003","volume":"209","author":"TH Webb","year":"1989","unstructured":"Webb TH, Lillemoe KD, Pitt HA, Jones RJ, Cameron JL. Pancreatic lymphoma. Is surgery mandatory for diagnosis or treatment? Ann Surg. 1989;209(1):25\u201330.","journal-title":"Ann Surg"},{"issue":"3","key":"4176_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1072-7515(99)00291-4","volume":"190","author":"LG Koniaris","year":"2000","unstructured":"Koniaris LG, Lillemoe KD, Yeo CJ, et al. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg. 2000;190(3):319\u2013330.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"4176_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0039-6060(98)70158-8","volume":"123","author":"M Bouvet","year":"1998","unstructured":"Bouvet M, Staerkel GA, Spitz FR, et al. Primary pancreatic lymphoma. Surgery. 1998;123(4):382\u2013390.","journal-title":"Surgery"},{"issue":"1","key":"4176_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/COC.0b013e3182354bbb","volume":"36","author":"MV Mishra","year":"2013","unstructured":"Mishra MV, Keith SW, Shen X, Bar Ad V, Champ CE, Biswas T. Primary pancreatic lymphoma: a population-based analysis using the SEER program. Am J Clin Oncol. 2013;36(1):38\u201343.","journal-title":"Am J Clin Oncol"},{"key":"4176_CR16","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008."},{"issue":"11","key":"4176_CR17","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J Clin Oncol. 1989;7(11):1630\u20131636.","journal-title":"J Clin Oncol"},{"key":"4176_CR18","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"issue":"5","key":"4176_CR19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u2013586.","journal-title":"J Clin Oncol"},{"issue":"4 Suppl","key":"4176_CR20","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jamcollsurg.2007.06.331","volume":"205","author":"PJ Allen","year":"2007","unstructured":"Allen PJ. Pancreatic adenocarcinoma: putting a hump in survival. J Am Coll Surg. 2007;205(4 Suppl):S76\u201380.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"4176_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"4176_CR22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gutjnl-2012-304224","volume":"62","author":"T Kamisawa","year":"2013","unstructured":"Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut. 2013;62(9):1373\u20131380.","journal-title":"Gut."},{"key":"4176_CR23","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology; version 1.2014. Available at: http:\/\/www.nccn.org\/\/professionals\/physician_gls\/pdf\/pancreatic.pdf . Accessed 20 Feb 2014."},{"issue":"5","key":"4176_CR24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clon.2012.02.005","volume":"24","author":"SS Ahmad","year":"2012","unstructured":"Ahmad SS, Idris SF, Follows GA, Williams MV. Primary testicular lymphoma. Clin Oncol. 2012;24(5):358\u2013365.","journal-title":"Clin Oncol"},{"issue":"5","key":"4176_CR25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.clon.2012.02.006","volume":"24","author":"NG Mikhaeel","year":"2012","unstructured":"Mikhaeel NG. Primary bone lymphoma. Clin Oncol. 2012;24(5):366\u2013370.","journal-title":"Clin Oncol"},{"issue":"7","key":"4176_CR26","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/1042819031000079195","volume":"44","author":"D Gholam","year":"2003","unstructured":"Gholam D, Bibeau F, El Weshi A, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma. 2003;44(7):1173\u20131178.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4176_CR27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.2006.06444.x","volume":"136","author":"PF Ferrucci","year":"2007","unstructured":"Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10\u00a0years? Br J Haematol. 2007;136(4):521\u2013538.","journal-title":"Br J Haematol"},{"issue":"19","key":"4176_CR28","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","volume":"24","author":"TM Habermann","year":"2006","unstructured":"Habermann TM, Weller EA, Morrison VA, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24(19):3121\u20133127.","journal-title":"J Clin Oncol"},{"issue":"14","key":"4176_CR29","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","volume":"28","author":"M Ziepert","year":"2010","unstructured":"Ziepert M, Hasenclever D, Kuhnt E, et al. Standard International Prognostic Index remains a valid predictor of outcome for patients with aggressive CD20+B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28(14):2373\u20132380.","journal-title":"J Clin Oncol"},{"key":"4176_CR30","unstructured":"American Cancer Society. Available at: http:\/\/www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-036845.pdf . Accessed at 1 Apr 2014."},{"issue":"10","key":"4176_CR31","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1200\/JCO.2013.51.5866","volume":"32","author":"MJ Maurer","year":"2014","unstructured":"Maurer MJ, Ghesquieres H, Jais JP, et al. Event-free survival at 24\u00a0months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32(10):1066\u20131073.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4176_CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/annonc\/mdm471","volume":"19","author":"G Ryan","year":"2008","unstructured":"Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2008;19(2):233\u2013241.","journal-title":"Ann Oncol"},{"issue":"5","key":"4176_CR33","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.1997.15.5.1745","volume":"15","author":"AY Lee","year":"1997","unstructured":"Lee AY, Connors JM, Klimo P, O\u2019Reilly SE, Gascoyne RD. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B. J Clin Oncol. 1997;15(5):1745\u20131753.","journal-title":"J Clin Oncol"},{"issue":"12","key":"4176_CR34","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.2009.24.5860","volume":"28","author":"JF Larouche","year":"2010","unstructured":"Larouche JF, Berger F, Chassagne-Clement C, et al. Lymphoma recurrence 5\u00a0years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. J Clin Oncol. 2010;28(12):2094\u20132100.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4176-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4176-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T03:06:29Z","timestamp":1598411189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4176-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,24]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4176-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,24]]}}}